Clinical Trials on Anaplastic Astrocytomas in Norway
Total 33 results
-
Haukeland University HospitalUniversity of BergenTerminatedGlioblastoma Multiforme | Anaplastic Astrocytoma | Tumor AngiogenesisNorway
-
Oslo University HospitalKarolinska University Hospital; University Hospital of North Norway; Sahlgrenska... and other collaboratorsRecruitingOligodendroglioma | Oligodendroglioma, Anaplastic | Diffuse Astrocytoma, IDH-MutantNorway
-
Oslo University HospitalRecruiting
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG Oncology; Eastern Cooperative Oncology Group and other collaboratorsCompletedBrain and Central Nervous System TumorsUnited States
-
Haukeland University HospitalUniversity of Oslo; Oslo University Hospital; University Hospital of North Norway and other collaboratorsRecruiting
-
Haukeland University HospitalNorthwell Health; University of Bergen; Weill Medical College of Cornell University and other collaboratorsCompletedGlioma | Glioblastoma | Recurrent GlioblastomaNorway
-
Oslo University HospitalInstitute for Molecular MedicineRecruitingRecurrent GlioblastomaNorway
-
Kyrre Eeg EmblemEnrolling by invitationGlioblastoma | Brain MetastasesNorway
-
Sahlgrenska University Hospital, SwedenKarolinska University Hospital; St. Olavs Hospital; University Hospital, Linkoeping and other collaboratorsCompleted
-
Novartis PharmaceuticalsCompletedMelanoma | Triple Negative Breast Cancer | Anaplastic Thyroid Cancer | Other Solid Tumors | Non-small Sell Lung Cancer (NSCLC)United States, Italy, Spain, Hungary, Taiwan, Germany, Netherlands, France, Norway, Poland, Thailand, Lebanon, Turkey, Canada
-
St. Olavs HospitalOdense University Hospital; Karolinska University Hospital; Turku University... and other collaboratorsRecruiting
-
Cellphire Therapeutics, Inc.Department of Health and Human ServicesCompletedHematologic Diseases | Thrombocytopenia | Bone Marrow AplasiaUnited States, Norway
-
Cellphire Therapeutics, Inc.Department of Health and Human ServicesTerminatedMyelodysplastic Syndromes | Myeloproliferative Disorders | Thrombocytopenia | Hematologic Malignancy | Bone Marrow Aplasia | Platelet RefractorinessUnited States, Israel, Norway
-
Boston Children's HospitalMassachusetts General Hospital; Mayo Clinic; Karolinska University Hospital; Baylor... and other collaboratorsActive, not recruitingAplastic Anemia | Dyskeratosis Congenita | Hoyeraal Hreidarsson Syndrome | Revesz SyndromeUnited States, Norway, Sweden
-
European Organisation for Research and Treatment...PfizerCompletedLocally Advanced and/or Metastatic Anaplastic Large Cell Lymphoma | Locally Advanced and/or Metastatic Inflammatory Myofibroblastic Tumor | Locally Advanced and/or Metastatic Papillary Renal Cell Carcinoma Type 1 | Locally Advanced and/or Metastatic Alveolar Soft Part Sarcoma | Locally Advanced... and other conditionsFrance, Belgium, Netherlands, Germany, United Kingdom, Italy, Norway, Poland, Slovakia, Slovenia
-
CelgeneActive, not recruitingGlioblastomaSpain, United States, Denmark, Italy, Netherlands, Norway, Sweden
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedAdult Anaplastic Oligodendroglioma | Adult Mixed Glioma | Adult Oligodendroglioma | Recurrent Adult Brain NeoplasmUnited States
-
European Organisation for Research and Treatment...Celgene; Canadian Cancer Trials GroupCompletedNewly Diagnosed GlioblastomaUnited States, Belgium, Canada, Spain, Netherlands, France, Switzerland, Germany, Norway, Denmark, Austria, United Kingdom
-
National Cancer Institute (NCI)Radiation Therapy Oncology GroupCompletedAdult Giant Cell Glioblastoma | Adult Glioblastoma | Adult GliosarcomaUnited States
-
Kartos Therapeutics, Inc.CompletedCancer | Glioblastoma | Multiple Myeloma | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology PatientsUnited States, France, Netherlands
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedGlioblastoma MultiformeUnited States
-
National Cancer Institute (NCI)CompletedAdult Giant Cell Glioblastoma | Adult Glioblastoma | Adult GliosarcomaUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedBrain CancerUnited States, Canada, Belgium, Spain, Australia, Netherlands, United Kingdom, Denmark, Norway, Japan, Sweden, France, Poland, Austria, Germany, Israel, Italy, Russian Federation, Switzerland
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedBrain NeoplasmsUnited States, Australia, Austria, Belgium, Canada, Denmark, France, Germany, Israel, Italy, Japan, Netherlands, Norway, Poland, Russian Federation, Spain, Sweden, Switzerland, United Kingdom
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States
-
Alliance for Clinical Trials in OncologyBristol-Myers Squibb; National Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States
-
National Cancer Institute (NCI)CompletedAdult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Recurrent Adult Brain TumorUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedRadiation Therapy Plus Chemotherapy in Treating Patients With Supratentorial Glioblastoma MultiformeBrain and Central Nervous System TumorsUnited States, Canada
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG Oncology; European Organisation for Research...CompletedBrain and Central Nervous System TumorsCanada, United States
-
National Cancer Institute (NCI)CompletedAdult Glioblastoma | Adult Gliosarcoma | Recurrent Adult Brain NeoplasmUnited States
-
National Cancer Institute (NCI)NRG OncologyCompletedGlioblastoma | Gliosarcoma | Recurrent Glioblastoma | Oligodendroglioma | Giant Cell Glioblastoma | Recurrent Brain NeoplasmUnited States, Canada